CR20220213A - Nuevo proceso químico para la elaboración de 6–cloro–4–(4–fluoro–2–metilfenil)piridin–3–amina, un intermediario clave de nt–814 - Google Patents
Nuevo proceso químico para la elaboración de 6–cloro–4–(4–fluoro–2–metilfenil)piridin–3–amina, un intermediario clave de nt–814Info
- Publication number
- CR20220213A CR20220213A CR20220213A CR20220213A CR20220213A CR 20220213 A CR20220213 A CR 20220213A CR 20220213 A CR20220213 A CR 20220213A CR 20220213 A CR20220213 A CR 20220213A CR 20220213 A CR20220213 A CR 20220213A
- Authority
- CR
- Costa Rica
- Prior art keywords
- methylphenyl
- fluoro
- pyridin
- chloro
- amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/44—Palladium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La invención se refiere a un nuevo proceso para la producción de compuesto 2–(3,5–bis(trifluorometil)fenil)–N–(6–cloro–4–(4–fluoro–2–metilfenil)piridin–3–il)–N,2–dimetilpropanamida (Compuesto IX), que es útil en la elaboración de Compuesto 2–[3,5–Bis(trifluorometil)fenil]–N–{4–(4–fluoro–2–metilfenil)–6–[(7S,9aS)–7–(hidroximetil)hexahidropirazino[2,1–c][1,4]oxazin–8(1H)–il]–3–piridinil}–N,2–dimetilpropanamida (Compuesto A).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19209562 | 2019-11-15 | ||
PCT/EP2020/081476 WO2021094247A1 (en) | 2019-11-15 | 2020-11-09 | New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of nt-814 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20220213A true CR20220213A (es) | 2022-07-08 |
Family
ID=68583265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20220213A CR20220213A (es) | 2019-11-15 | 2020-11-09 | Nuevo proceso químico para la elaboración de 6–cloro–4–(4–fluoro–2–metilfenil)piridin–3–amina, un intermediario clave de nt–814 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20230002322A1 (es) |
EP (1) | EP4058433A1 (es) |
JP (1) | JP2023501666A (es) |
KR (1) | KR20220101090A (es) |
CN (1) | CN114728906A (es) |
AR (1) | AR120468A1 (es) |
AU (1) | AU2020381762A1 (es) |
CA (1) | CA3161336A1 (es) |
CO (1) | CO2022006071A2 (es) |
CR (1) | CR20220213A (es) |
IL (1) | IL292921A (es) |
JO (1) | JOP20220111A1 (es) |
MX (1) | MX2022005867A (es) |
PE (1) | PE20221167A1 (es) |
TW (1) | TW202128625A (es) |
WO (1) | WO2021094247A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP20237503B (en) | 2018-03-14 | 2023-04-25 | Kandy Therapeutics Ltd | Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
TWI259180B (en) | 2000-08-08 | 2006-08-01 | Hoffmann La Roche | 4-Phenyl-pyridine derivatives |
DK1643998T3 (da) | 2003-07-03 | 2007-12-27 | Hoffmann La Roche | NK1/NK3-antagonister til behandling af skizofreni |
US20060030600A1 (en) | 2004-08-06 | 2006-02-09 | Patrick Schnider | Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia |
DE602006021323D1 (de) * | 2005-09-09 | 2011-05-26 | Glaxosmithkline Llc | Pyridinderivate und ihre verwendung bei der behandlung psychotischer erkrankungen |
CN102639536B (zh) | 2009-08-27 | 2015-03-18 | 尼尔医疗有限公司 | 吡啶衍生物的无水晶型 |
US9403772B2 (en) | 2011-11-29 | 2016-08-02 | Helsinn Healthcare Sa | 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator |
WO2015068744A1 (ja) | 2013-11-08 | 2015-05-14 | キッセイ薬品工業株式会社 | カルボキシメチルピペリジン誘導体 |
TWI649307B (zh) | 2014-05-07 | 2019-02-01 | 日商橘生藥品工業股份有限公司 | Cyclohexylpyridine derivative |
EP3297631B1 (en) | 2015-05-18 | 2019-09-04 | NeRRe Therapeutics Limited | Nk-1/nk-3 receptor antagonist for the treatment of hot flushes |
GEP20237503B (en) | 2018-03-14 | 2023-04-25 | Kandy Therapeutics Ltd | Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists |
-
2020
- 2020-11-09 JP JP2022528104A patent/JP2023501666A/ja active Pending
- 2020-11-09 EP EP20800691.6A patent/EP4058433A1/en active Pending
- 2020-11-09 CR CR20220213A patent/CR20220213A/es unknown
- 2020-11-09 WO PCT/EP2020/081476 patent/WO2021094247A1/en unknown
- 2020-11-09 CA CA3161336A patent/CA3161336A1/en active Pending
- 2020-11-09 AU AU2020381762A patent/AU2020381762A1/en active Pending
- 2020-11-09 KR KR1020227015846A patent/KR20220101090A/ko unknown
- 2020-11-09 MX MX2022005867A patent/MX2022005867A/es unknown
- 2020-11-09 PE PE2022000788A patent/PE20221167A1/es unknown
- 2020-11-09 CN CN202080078913.9A patent/CN114728906A/zh active Pending
- 2020-11-09 US US17/776,805 patent/US20230002322A1/en active Pending
- 2020-11-09 IL IL292921A patent/IL292921A/en unknown
- 2020-11-09 JO JOP/2022/0111A patent/JOP20220111A1/ar unknown
- 2020-11-13 AR ARP200103159A patent/AR120468A1/es unknown
- 2020-11-13 TW TW109139706A patent/TW202128625A/zh unknown
-
2022
- 2022-05-10 CO CONC2022/0006071A patent/CO2022006071A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA3161336A1 (en) | 2021-05-20 |
CN114728906A (zh) | 2022-07-08 |
IL292921A (en) | 2022-07-01 |
AU2020381762A1 (en) | 2022-06-02 |
US20230002322A1 (en) | 2023-01-05 |
TW202128625A (zh) | 2021-08-01 |
WO2021094247A1 (en) | 2021-05-20 |
KR20220101090A (ko) | 2022-07-19 |
JP2023501666A (ja) | 2023-01-18 |
CO2022006071A2 (es) | 2022-05-20 |
MX2022005867A (es) | 2022-06-14 |
EP4058433A1 (en) | 2022-09-21 |
PE20221167A1 (es) | 2022-07-25 |
AR120468A1 (es) | 2022-02-16 |
JOP20220111A1 (ar) | 2023-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ594776A (en) | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors | |
NZ597140A (en) | Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives | |
FI114469B (fi) | Kortikotropiinia vapauttavan tekijän antagonisteja | |
CR20220213A (es) | Nuevo proceso químico para la elaboración de 6–cloro–4–(4–fluoro–2–metilfenil)piridin–3–amina, un intermediario clave de nt–814 | |
HRP20110457T1 (hr) | Derivati piridina i njihova upotreba u liječenju psihotičnih poremećaja | |
NZ599040A (en) | 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases | |
PE20050348A1 (es) | Metanosulfonato del ester etilico del acido 3-[ (2-{ [4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil} -1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino] -propionico | |
NZ628583A (en) | 6 - alkynyl pyridines as smac mimetics | |
NZ607845A (en) | Besylate salt of a btk inhibitor | |
PE20140832A1 (es) | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak | |
PE20170004A1 (es) | Inhibidores de biaril cinasa | |
PE20061120A1 (es) | Compuesto de heteroarilo como inhibidores del receptor p2y1 | |
EA201301319A1 (ru) | Производные пиридин-2(1н)-она, применимые в качестве лекарственных средств для лечения миелопролиферативных нарушений, отторжения трансплантата, иммунологически обусловленных и воспалительных заболеваний | |
PE20141023A1 (es) | Derivados de (1,2,4) triazolo [4,3-a] quinoxalina como inhibidores de fosfodiesterasas | |
HK1158650A1 (en) | Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2- (trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3- carboxamide n-(4-(7-[221]-7-)-2-())-4--5-()-1 4--3- | |
PE20130188A1 (es) | Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk | |
GEP20197050B (en) | Solid state forms of fused heteroaromatic pyrrolidinones | |
WO2012044727A3 (en) | Manufacturing process for pyrimidine derivatives | |
MX2022005706A (es) | Formulacion farmaceutica novedosa que comprende antagonistas del receptor dual nk-1/nk-3. | |
EA201400182A1 (ru) | Производные пиридин-2(1н)-она в качестве ингибиторов jak | |
HRP20240161T1 (hr) | Inhibitor atr i njegova primjena | |
RU2012114846A (ru) | Соединение глицина | |
MX2020010948A (es) | Proceso para la preparacion de (s)-2-((2-((s)-4-(difluorometil)-2- oxooxazolidin-3-il)-5,6-dihidrobenzo[f]imidazo[1,2-d] [1,4]oxazepin-9-il)amino)propanamida. | |
MY149058A (en) | N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b | |
MX337638B (es) | Isoxazolo [5, 4-b] piridinas herbicidas. |